Wang, H.; He, W.; Elizondo-Riojas, M.-A.; Zhou, X.; Lee, T.J.; Gorenstein, D.G.
Development and Characterization of CD44-Targeted X-Aptamers with Enhanced Binding Affinity for Cancer Therapeutics. Bioengineering 2025, 12, 113.
https://doi.org/10.3390/bioengineering12020113
AMA Style
Wang H, He W, Elizondo-Riojas M-A, Zhou X, Lee TJ, Gorenstein DG.
Development and Characterization of CD44-Targeted X-Aptamers with Enhanced Binding Affinity for Cancer Therapeutics. Bioengineering. 2025; 12(2):113.
https://doi.org/10.3390/bioengineering12020113
Chicago/Turabian Style
Wang, Hongyu, Weiguo He, Miguel-Angel Elizondo-Riojas, Xiaobo Zhou, Tae Jin Lee, and David G. Gorenstein.
2025. "Development and Characterization of CD44-Targeted X-Aptamers with Enhanced Binding Affinity for Cancer Therapeutics" Bioengineering 12, no. 2: 113.
https://doi.org/10.3390/bioengineering12020113
APA Style
Wang, H., He, W., Elizondo-Riojas, M.-A., Zhou, X., Lee, T. J., & Gorenstein, D. G.
(2025). Development and Characterization of CD44-Targeted X-Aptamers with Enhanced Binding Affinity for Cancer Therapeutics. Bioengineering, 12(2), 113.
https://doi.org/10.3390/bioengineering12020113
